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IP3Rs (inositol 1,4,5-trisphosphate receptors) are the intracellular
channels that mediate release of Ca2+ from the endoplasmic
reticulum in response to the many stimuli that evoke Ins(1,4,5)P3
formation. We characterized and purified type 1 IP3R hetero-
logously expressed in Sf9 insect cells, and used the purified
IP3R1 to determine its three-dimensional structure by electron
microscopy and single-particle analysis. Recombinant IP3R1
has 4-fold symmetry with overall dimensions of approx.
19.5 nm × 19.5 nm × 17.5 nm. It comprises a small domain,
which is likely to include the pore, linked by slender bridges
to a large cytoplasmic domain with four petal-like regions.
Our structures of recombinant IP3R1 and native cerebellar IP3R
have similar appearances and dimensions. The only notable
difference is the absence of a central stigma-like domain from
the cytoplasmic region of recombinant IP3R1. The first structure
of a recombinant IP3R is an important step towards developing
three-dimensional structures of IP3R that better contribute to our
understanding of the structural basis of IP3R activation.
Key words: calcium channel, electron microscopy (EM), inositol
1,4,5-trisphosphate receptor (IP3R), single-particle analysis
(SPA).
INTRODUCTION
Cytosolic Ca2+ signals regulate diverse cellular activities and most
of these signals arise from regulated opening of Ca2+-permeable
channels. IP3Rs (inositol 1,4,5-trisphosphate receptors) are the
most widely expressed of these channels [1]. Most IP3Rs are
expressed in membranes of the ER (endoplasmic reticulum), but
they are present also in the plasma membrane of some cells
[2], in the nuclear envelope [3], in the Golgi apparatus [4] and
perhaps also in secretory vesicles [5]. Three vertebrate genes
encode closely related subunits of IP3Rs, each comprising ∼2700
amino acid residues. The functional IP3R is a homo- or hetero-
tetrameric assembly of these subunits [6–8]. Each subunit has
a single Ins(1,4,5)P3-binding site, the Ins(1,4,5)P3-binding core
(residues 224–604), which comprises two domains forming a
clam-like structure that encloses a positively charged pocket to
which Ins(1,4,5)P3 binds [9]. The N-terminal of the IP3R (residues
1–223), the suppressor domain, is the only other region of the IP3R
for which a high-resolution structure is available [10]. The head
of its hammer-like structure forms a β-trefoil, whereas the
handle comprises a helix–turn–helix motif [10]. Although
the structural basis of IP3R activation remains poorly understood,
it is clear that the suppressor domain provides an essential link
between Ins(1,4,5)P3 binding to the Ins(1,4,5)P3-binding core
and opening of the pore [11,12]. Furthermore, the N-terminal of
RyRs (ryanodine receptors), another major family of intracellular
Ca2+ channels, has a structure almost indistinguishable from that
of the suppressor domain of IP3R1 [13], suggesting that both
families of intracellular Ca2+ channels may share similar gating
mechanisms. For both RyRs and IP3Rs, the Ca2+-permeable pore
of the channel is formed by the last pair of the six transmembrane
helices of each subunit together with the luminal loop that links
them. Intermediate-resolution structures of RyR, derived from
SPA (single-particle analysis) [14,15], together with sequence
alignments [16,17] and mutagenesis [2,18] of both RyR [16,17]
and IP3R [2,18,19] are consistent with the idea that the pore
of both channels has a structure broadly similar to that of K+
channels [20], with each pair of transmembrane helices cradling
an intervening pore helix and selectivity filter. A direct interaction
between the suppressor domain and the cytosolic helix that links
the fourth and fifth transmembrane domains may mediate gating
of IP3R [11,12].
High-resolution structures of the complete IP3R are ultimately
required if the structural basis of its activation is to be fully
resolved. To date, five intermediate-resolution (∼30 Å, where
1 Å = 0.1 nm) structures of IP3R1 purified from cerebellum have
been determined using EM (electron microscopy) and SPA [21–
25]. These structures differ in their details, but they all show a
4-fold symmetry and have two distinct regions: a large cytoplas-
mic domain and a small domain, which is assumed to include the
channel region [26]. The first three-dimensional structure to be
published had the shape of an uneven dumbbell with a height of
17 nm, and with four arms radiating from the large cytoplasmic
domain [22]. We presented a structure reminiscent of a flower, in
which the stalk represents the channel domain, and the cytoplas-
mic regions are represented by the petals and stigma with overall
dimensions of ∼18 nm × 18 nm × 18 nm [23]. Serysheva et al.
[24] described the structure of IP3R as a large cytoplasmic pin-
wheel with a smaller square-shaped transmembrane domain; its
overall dimensions were ∼25 nm × 25 nm × 19 nm. Hamada and
Mikoshiba [28] compared the three-dimensional structures with
and without Ca2+ and suggested that Ca2+ caused IP3R to switch
from a mushroom-like (∼19 nm × 19 nm × 16 nm) to a windmill-
like (∼22 nm × 22 nm × 18 nm) shape, with the head of
the mushroom and the wings of the windmill representing
cytosolic domains [21]. The most recent structure resembles
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a heavily fenestrated hot-air balloon with dimensions of
∼17 nm × 17 nm × 23 nm [25]. In the 7–8 years since the publi-
cation of the first three-dimensional structures of native IP3R
[22–24,28], there has been no significant progress towards the
higher-resolution structures that are required if the structures are
to contribute further to our understanding of the workings of IP3R.
One approach, with considerable potential to accelerate pro-
gress, is to extend EM and SPA analyses of the three-dimensional
structure from native IP3R to recombinant proteins. The benefits
might include simplified purification procedures (using tagged
IP3R), isolation of more homogeneous protein samples than are
likely to be present in native tissues, and the opportunity to
introduce tags identifiable by EM to allow mapping of primary
sequence to the three-dimensional structure. Similar approaches
applied to RyR [29–32] have allowed our understanding of
its three-dimensional structure to progress well beyond that
of IP3R [33]. In the present study, we used EM and SPA to
establish the first three-dimensional structure of recombinant
IP3R1 heterologously expressed in Sf9 insect cells.
EXPERIMENTAL
Materials
Fetal bovine serum, primers, fungizone, gentamicin and BSA
were from Sigma. ATP and CompleteTM protease inhibitor
cocktail were from Roche. DDM (dodecyl maltoside) was from
Calbiochem. Restriction enzymes and most molecular biology
reagents were from New England Biolabs. [3H]Ins(1,4,5)P3 (18
Ci/mmol) was from PerkinElmer Life Sciences, and Ins(1,4,5)P3
was from Alexis Biochemicals. PreScission protease and the
HiTrap Q FF and Superose 6 10/300 GL columns were from
GE Healthcare. Mag-fluo-4AM and Sf-900 II SFM medium
were from Invitrogen. Other materials were from Sigma, Fisher
Scientific or the sources specified in the text or earlier publications
[12,34].
Expression of IP3R1 in Sf9 cells
A pENTR1A vector encoding IP3R1 N-terminally tagged with
ECFP (enhanced cyan fluorescent protein) (ECFP–IP3R1) was
prepared from two existing pENTR1A vectors containing full-
length rat IP3R1 (GenBank® accession number GQ233032.1)
and another containing an ECFP-tagged N-terminus of IP3R1
(residues 1–604) by ligation after digestion with NheI and
KpnI. The product provided the template from which PCR
was used to engineer a C-terminal biotinylation sequence and
PreScission cleavage site (Figure 1A). The reverse primer (5′-
TGCATCTCGAGTTATTCGTGCCATTCTATTTTTTGTGCTT-
CAAAGATGTCGTTGAGTCCGGGCCCCTGGAACAGAAC-
TTCCAGGGCTGGCTGCTGTGGGTTGACATTCATGTG-3′)
introduced the PreScission cleavage site and biotinylation
sequence (Figure 1A). The forward primer [5′-ATGCAGAA-
TTCGGATCCTGTACAACATGAGGCCCAAG-3′, correspond-
ing to bases (underlined) 6326–6351 of IP3R1] used a unique
BstBI site near the 3′ end of the open reading frame. The PCR
product and ECFP–IP3R1 plasmid were digested with BstBI
and XhoI and ligated to give a pENTR1A plasmid encoding the
tagged IP3R1 shown in Figure 1(A). This IP3R1 construct was
then transferred into artificial baculovirus DNA (BaculoDirect
Linear DNA, Invitrogen) to create recombinant baculovirus
DNA. High-titre viral stocks were prepared and the titre was
determined by end-point dilution [35]. The sequence of the final
construct was verified by DNA sequencing.
Figure 1 Recombinant IP3R1 is functional
(A) The recombinant IP3R1 used has an N-terminal ECFP tag, a PreScission protease cleavage
site (Pr) and the biotinylation sequence (biotin). (B) Ins(1,4,5)P3-evoked Ca2+ release from
permeabilized Sf9 cells with or without expression of recombinant IP3R1. (C) Specific binding
of [3H]Ins(1,4,5)P3 (1.5 nM) in the presence of the indicated concentrations of Ins(1,4,5)P3
(IP3) to membranes prepared from Sf9 cells expressing recombinant IP3R1. Results (B and C)
are means +− S.E.M (n = 3).
Sf9 cells were grown in Sf-900 II SFM medium supplemented
with 10% fetal bovine serum, 2% fungizone and 1% gentamicin
at pH 6.2 in flasks for virus production, and in spinner flasks
(stirred at 70 rev./min) or shaking bottles (at 135 rev./min) for
protein expression. Cultures were maintained at 27 ◦C in a humid
environment, and passaged every 7 days or when the density
exceeded 2 × 106 cells/ml. For protein expression, Sf9 cells
were infected with ten virus particles/cell [MOI (multiplicity of
infection) = 10] and harvested after 60 h.
Purification of IP3R1 from Sf9 cells
All procedures were performed at 4 ◦C, with incubations mixed
by gentle rotation at 15 rev./min. Infected cells (3.2 × 109) were
harvested by centrifugation at 700 g for 5 min, washed with TEM
(Tris/EDTA medium: 50 mM Tris/HCl, 1 mM EDTA, pH 8.3, and
protease inhibitor cocktail) and centrifuged at 700 g for 5 min. The
pellet was suspended in TEM, homogenized with an Ultra Turrax
(9500 rev./min, two rounds of ten strokes) and then with a glass
homogenizer (60 strokes), centrifuged at 900 g for 10 min, and
the supernatant was then centrifuged at 46760 rev./min for 1 h
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using a Beckman 70.1 Ti rotor. The pellet was suspended in TEM
(7 ml) and biotinylated by incubation for 12–16 h with D-biotin
(100 μM) and biotin–protein ligase (BirA, 9 μg in a final volume
of 10 ml) according to the manufacturer’s instructions (Avidity).
Membranes were recovered by centrifugation at 46760 rev./min
for 1 h using a Beckman 70.1 Ti rotor.
Biotinylated membranes (16 mg of total protein/ml) were
solubilized in PBM (phosphate-buffered medium: 100 mM
Na2HPO4/NaH2PO4, 1 mM ETDA, 5% glycerol, 150 mM NaCl,
pH 8, protease inhibitor cocktail and 1% DDM). The yield
(∼40%) after solubilization was lower than we and others
have obtained using Triton X-100, but DDM is more widely
used for solubilization of proteins for structural studies, and the
background signals in EM were much lower with DDM than
with Triton X-100. After 4 h, the supernatant was recovered
after centrifugation at 46760 rev./min for 1 h using a Beckman
70.1 Ti rotor and incubated for 1 h with streptavidin–agarose
beads (Invitrogen) at 2 mg of protein/100 μl of beads. The beads
(100 μl) were washed twice with PBM and then resuspended in
100 μl of PrM (PreScission medium: 50 mM Tris/HCl, 150 mM
NaCl, 1 mM EDTA, 1 mM dithiothreitol and 0.2% DDM,
pH 7) containing PreScission protease (4 units/100 μl of beads).
After incubation for 12 h, the supernatant was collected by
centrifugation at 650 g for 5 min and applied to a HiTrap Q
FF anion-exchange column, which was then washed (100 ml,
1 ml/min) with ion-exchange medium (50 mM Tris/HCl, 150 mM
NaCl, 1 mM EDTA, 1 mM dithiothreitol, 5% glycerol and 0.02%
DDM, pH 8.3). A linear gradient (150–500 mM NaCl in the
same medium) was used to elute fractions of 0.5 ml, and the
peak fractions (numbers 17–25) were pooled and concentrated to
0.5 ml with a Vivaspin-2 MWCO (molecular-mass cut-off) 30000
centrifugal concentrator (Sartorius). The concentrated sample
was applied to a Superose 6 10/300 GL gel-filtration column,
and fractions (0.5 ml) were eluted with ion-exchange medium
(0.5 ml/min). Fractions 21–22 were pooled and used for EM.
Samples were analysed using pre-cast SDS/PAGE mini-gels
(Invitrogen), and by immunoblotting using the iblot system (Invi-
trogen) with a rabbit peptide antiserum (1:1000) against the
C-terminus of IP3R1 [12]. Anti-rabbit horseradish peroxidase-
conjugated secondary antibody (AbCam, 1:5000) and Super
Signal West Pico chemiluminescence reagent (Pierce) were used
to detect immunoreactivity. The bands were quantified using
GeneTools (Syngene). Protein gels were silver-stained
using GelCode SilverSNAP II stain kit according to the manu-
facturer’s instructions (Pierce).
Ins(1,4,5)P3-evoked Ca2+ release from intracellular stores
The free [Ca2+] within the ER was recorded using a low-
affinity luminal Ca2+ indicator, Mag-fluo-4, and a FlexStation
plate-reader (MDS Analytical Technologies) [34]. Sf9 cells
(∼2 × 106/ml) were incubated for 1 h at 20 ◦C with Mag-fluo-
4AM (20 μM) in Hepes-buffered medium (135 mM NaCl,
5.9 mM KCl, 11.6 mM Hepes, 1.5 mM CaCl2, 11.5 mM
glucose and 1.2 mM MgCl2, pH 7.3) containing BSA
(1 mg/ml) and Pluronic F127 (0.4 mg/ml). The cells were
then resuspended in Ca2+-free CLM {cytosol-like medium:
20 mM NaCl, 140 mM KCl, 2 mM MgCl2, 1 mM EGTA,
375 μM CaCl2 (free [Ca2+] ∼200 nM) and 20 mM Pipes, pH 7}
containing saponin (10 μg/ml). After ∼10 min at 37 ◦C, the
permeabilized cells were washed (650 g, 3 min), resuspended
in Mg2+-free CLM with 10 μM FCCP (carbonyl cyanide
p-trifluoromethoxyphenylhydrazone), distributed into 96-well
plates (6 × 105 or 2 × 105 cells in 50 μl/well, for uninfected and
infected cells respectively) and centrifuged at 1000 g for 3 min.
After addition of MgATP (1.5 mM), the intracellular stores were
loaded to steady-state with Ca2+, and, after 150 s, Ins(1,4,5)P3
was added with thapsigargin (1 μM); the latter to inhibit further
Ca2+ uptake. Ins(1,4,5)P3-evoked Ca2+ release is expressed as a
fraction of the ATP-dependent Ca2+ uptake. Concentration–effect
relationships were fitted to a Hill equation using non-linear
curve-fitting (GraphPad Prism, version 5).
[3H]Ins(1,4,5)P3 binding
Equilibrium-competition binding assays were performed at
4 ◦C in TEM (500 μl) containing [3H]Ins(1,4,5)P3 (1.5 nM),
membranes (∼30 μg) or purified IP3R (∼0.7 μg), and
appropriate concentrations of Ins(1,4,5)P3. After 5 min, during
which equilibrium was attained, incubations were terminated
by the addition of ice-cold TEM (500 μl) containing PEG
[poly(ethylene glycol)] 8000 (30%) and γ -globulin (20 μl of
25 mg/ml), mixed, incubated on ice for 5 min and then centrifuged
at 20000 g for 5 min. The pellet was rinsed twice with 500 μl of
TEM containing 15% PEG 8000, and then resuspended to allow
its radioactivity to be determined by liquid scintillation counting.
Results were fitted to a Hill equation using GraphPad Prism from
which the IC50 and Kd were determined.
EM and image analysis
Purified IP3R1 was loaded on to glow-discharged carbon-coated
copper grids and negatively stained with 2% uranyl acetate.
Micrographs were collected on a Tecnai T-12 electron microscope
in low-dose mode (20 electrons/Å2) at a calibrated magnification
of 41125, at 120 kV with ∼700 nm defocus. The quality of
the micrographs was assessed using an optical diffractometer.
Only micrographs with circular and isotropic diffraction rings
(Thon rings) consistent with a resolution of at least 20 Å within
the first ring were used for further processing. Micrographs
were digitized using a Nikon Coolscan 9000ED at a step size
of 6.35 μm. Scanned micrographs were then converted for
processing using IMAGIC programs [36] and 3-pixel × 3-pixel
areas were averaged, resulting in a final pixel size of 0.45 nm. The
particles were selected with a box size of 100 pixels × 100 pixels
using the BOXER tool of the EMAN package [37]. IMAGIC [36]
was used for all other image processing, except for the multi-
reference alignment routine for which SPIDER [38] was used. In
the first multi-reference alignment and first angular assignment,
our previously published IP3R structure [23], filtered to 54 Å,
was used as a reference. The resolution of the three-dimensional
reconstruction was determined using the half-bit criterion.
RESULTS AND DISCUSSION
Expression, purification and characterization of recombinant IP3R1
After optimization of methods, the outcome of which is described
in the Experimental section, we established that infection of
Sf9 cells with the tagged IP3R1 construct shown in Figure 1(A)
allowed the expression of functional IP3R at a level considerably
exceeding that of endogenous IP3R. Immunoblotting confirmed
expression of IP3R1 of appropriate size (∼300 kDa, see below)
in the infected cells. After permeabilization, control and infected
cells were each able to accumulate Ca2+ after the addition
of ATP. Ins(1,4,5)P3 caused a barely resolvable Ca2+ release
from the control cells (maximal Ca2+ release, 7 +− 1%; EC50,
0.50 +− 0.05 μM; Hill coefficient, 0.9 +− 0.17), but caused a
very much larger release from the infected cells (maximal
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Figure 2 Purification of recombinant IP3R
(A and B) Silver-stained gel (A, 0.12 μg of protein/lane) and immunoblot with an IP3R1-specific antiserum (B, 0.12 μg of protein/lane) of purified recombinant IP3R1 from fractions 20–24 of
the gel-filtration step. Molecular-masses are shown in kDa. Results are typical of at least five similar analyses. (C) Specific binding of [3H]Ins(1,4,5)P3 (1.5 nM) in the presence of the indicated
concentrations of Ins(1,4,5)P3 to purified recombinant IP3R1 (means +− S.E.M, n = 3). (D) Electron micrograph of purified recombinant IP3R1 highlighting particles (arrows) with the expected size
of tetrameric IP3R (∼20 nm diameter). Scale bar, 70 nm.
Ca2+ release, 47 +− 2%; EC50, 1.6 +− 0.41 μM; Hill coefficient,
1.1 +− 0.17) (Figure 1B). In equilibrium-competition assays with[3H]Ins(1,4,5)P3 using membranes prepared from infected Sf9
cells, Ins(1,4,5)P3 bound with high affinity (Kd, 10.49 +− 1.06 nM,
Hill coefficient, 0.80 +− 0.08) and the density of the sites (Bmax)
was 10.6 +− 0.8 pmol/mg of protein (Figure 1C). The affinity
of the tagged IP3R1 expressed in Sf9 cells is similar to that
determined under the same conditions for native IP3R1 in cere-
bellar membranes [12] and of untagged IP3R1 expressed in Sf9
cells [23,39,40], and the level of expression is ∼40-fold higher
than that of native IP3R in Sf9 cells [40].
After biotinylation and solubilization (∼40% yield), recom-
binant IP3R1 was purified using streptavidin and then cleavage
by PreScission protease (∼50% yield), anion-exchange (∼16%
yield) and size-exclusion (∼70% yield) chromatography (see the
Experimental section). Calibration of the final chromatography
step suggested an oligomeric size for the purified IP3R of
∼1.56 MDa, which is consistent with the predicted size
of a tetramer of ECFP-tagged IP3R subunits (4 × 339 kDa)
associated with DDM (see Supplementary Figure S1 at
http://www.BiochemJ.org/bj/428/bj4280483add.htm). The final
product migrated as a single band of appropriate size after
SDS/PAGE and silver-staining (Figure 2A) or immunoblotting
with an IP3R1-selective antiserum (Figure 2B). The Kd of the
purified IP3R for Ins(1,4,5)P3 was 7.65 +− 0.69 nM, the Hill
coefficient was 1.1 +− 0.09 (Figure 2C), and the final specific
activity of the sites was 0.25 +− 0.02 nmol/mg of protein (their
concentration was 24 μg of IP3R/ml). Electron micrographs of
purified IP3R1 showed particles of the expected size (∼20 nm)
with their 4-fold symmetry clearly apparent in several profiles
(Figure 2D).
These results establish that we have successfully expressed
functional IP3R1 at high levels in Sf9 cells and purified them
under conditions that allow their structure to be analysed by EM
and SPA.
Three-dimensional structure of recombinant IP3R1
The final dataset included 7064 particles selected from scanned
micrographs. Particles were picked only if they were separated
from others and had a size appropriate for an IP3R (∼20 nm).
The centred, but otherwise unaligned, particles were subject to
multivariate statistical analysis, which yielded 69 eigenimages;
the first ten are shown in Figure 3(A). A 4-fold symmetry
is clearly visible in eigenimages 7 and 8, and a 3-fold symmetry is
visible in eigenimages 3 and 4. The apparent 3-fold symmetry may
reflect a side view of the IP3R, which published structures have
suggested may be approximately triangular [23,28]. Much of the
data comprises these side views or near side views, with only
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Figure 3 Image analysis of IP3R particles
(A) Eigenimages of the unaligned dataset. Eigenimage 1 shows the sum of all images. Eigenimages 3 and 4 show approx. 3-fold symmetry. Eigenimages 5 and 6 show approx. 2-fold symmetry.
Eigenimages 7 and 8 show 4-fold symmetry. (B) Class averages obtained independently after two iterative alignments (reference-free classes). (C) Similar class averages obtained after three
iterative alignments using the filtered three-dimensional structure of native IP3R [23] as a reference for the first alignment. (D) Class averages used for the final three-dimensional reconstruction.
(E) Re-projections of the final three-dimensional reconstruction corresponding to the class averages shown in (D). (F) Surface views of the final three-dimensional reconstruction in the same
orientations as the class averages. Scale bars (A–F), 20 nm.
a fraction of the unaligned data showing 4-fold symmetry. The
2-fold symmetry in eigenimages 5 and 6 is probably caused by
particles that correspond to slightly tilted top or bottom views.
Because the IP3R is tetrameric [26,41] (Supplementary Figure
S1) and all previous EM analyses established a 4-fold symmetry
[21–25], we applied C4 symmetry to the later stages of our three-
dimensional reconstruction.
Class averages of the IP3R were calculated after reference-free
alignment using IMAGIC and then refined using the SPIDER
alignment routine using class averages of the initial reference-
free alignment (Figure 3B). Figure 3(C) shows the class averages
obtained using native IP3R [23] as a reference. For the three-
dimensional reconstruction, recombinant IP3R particles were
aligned using the filtered native IP3R structure [23] as a reference
in the first iteration; these are similar to the reference-free class
averages (Figure 3B). Well-preserved classes with good signal-
to-noise ratios were selected and back-projected to produce three-
dimensional maps used for further refinement of the classes. The
class averages of each iteration cycle were used to obtain a three-
dimensional reconstruction that was then used as a reference for
the subsequent alignment. The three-dimensional reconstruction
was stable after the third iteration. The fast stabilization of the
analysis probably arises from our use of a refined structure of the
IP3R [23] as an initial reference.
The final three-dimensional reconstruction contained 22 class
averages with a good signal-to-noise ratio (Figures 3D–3F) and
a wide distribution of Euler angles (see Supplementary Fig-
ure S2 at http://www.BiochemJ.org/bj/428/bj4280483add.htm).
The resolution, measured using the half-bit criterion of the Fourier
shell correlation, was approx. 40 Å (see Supplementary Fig-
ure S3 at http://www.BiochemJ.org/bj/428/bj4280483add.htm).
The three-dimensional volume was contoured to accommodate
a molecular mass of the recombinant IP3R1 of 1.3 MDa
assuming a protein density of 844 Da/nm3. Figure 4(A) shows
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Figure 4 Structure of recombinant IP3R1
(A) Each section (1–40) is 0.45 nm thick and viewed along the symmetry axis starting from
the cytoplasmic end (1) to the end likely to be within the ER lumen (40). Scale bar, 10 nm. (B)
Surface views of the three-dimensional reconstruction of recombinant IP3R1 viewed from the
cytosol (i), from the lumen of the ER (ii) and two views in cross-section (iii and iv). (C) Views
similar to those shown in (B), but for native cerebellar IP3R [23]. Scale bars (B and C), 20 nm.
the structure of the recombinant IP3R as sections (each 0.45 nm
thick) cut along the symmetry axis and Figure 4(B) shows four
characteristic views of the final three-dimensional reconstruction.
The overall dimensions of the three-dimensional structure are
∼19.5 nm × 19.5 nm × 17.5 nm. It comprises a large cytoplasmic
region (∼19.5 nm × 19.5 nm × 10 nm) consisting of four petal-
like domains (each ∼10.6 nm wide) each connected to a smaller
stalk-like channel region (∼13.2 nm × 13.2 nm × 7.5 nm). This
region tapers towards the luminal side to a width of ∼7.4 nm
(Figures 4A and 4B).
Comparison of the structures of native and recombinant IP3R
and RyR
The three-dimensional structure of recombinant IP3R1, which
is likely to be in a closed state, resembles the flower model
of the native IP3R1 [23] (Figure 4C), but without the central
stigma. The overall dimensions of the two structures are
also similar: ∼18 nm × 18 nm × 18 nm for native IP3R1,
and ∼19.5 nm × 19.5 nm × 17.5 nm for recombinant IP3R1
(Figures 4B and 4C). The cytoplasmic region of each structure
is ∼11 nm high, and both have a putative channel region that
tapers towards the luminal side to a width of ∼7 nm. The only
substantial difference between the two structures is the absence
of a central stigma-like domain from the large cytoplasmic re-
gion of recombinant IP3R1 (compare Figures 4B, i and 4C, i).
It is unlikely that this results from inappropriate assembly of the
tetrameric IP3R because the recombinant protein was functional
and bound Ins(1,4,5)P3 with appropriate affinity (Figures 1B and
1C). It may be that the N-terminal ECFP tag stabilized a different
closed conformation of the IP3R or that the central stigma may
represent an accessory protein [42] that is not present in the
heterologous expression system. The three-dimensional structure
of a native IP3R1 in a closed state from another group [21] and our
structure of recombinant IP3R1 have similar overall dimensions
(19 nm × 19 nm × 16 nm) and similarly sized channel domains
(11 nm × 11 nm × 5.2 nm), and both lack a central stigma.
However, the four cytoplasmic petal-like regions of our structure
are discrete (Figure 4B, iii), but they are linked by slender bridges
in the native structure [21]. A possible explanation is that the
threshold set for the native model (1.7 MDa) is larger than
the actual size of native IP3R (1.2 MDa), leading to inclusion
of more density. The pinwheel structure of the native IP3R [24]
has slightly larger dimensions (∼25 nm × 25 nm × 19 nm), but
it shares the four petal-like features of the recombinant IP3R
structure, although their links with the channel region are both
more substantial and more centrally placed than in our structure
(Figure 4B). The two remaining structures of native IP3R [22,25]
have similar dimensions to published structures of native IP3R
and to our structure of recombinant IP3R1, but neither has
obvious petal-like domains or a stalk-like channel domain.
RyRs and IP3Rs are relatives that share many structural and
functional features, although IP3Rs are only half the size of
RyRs. Both are cation channels with relatively weak selectivity
for bivalent over univalent cations (PBa/PK ∼7), although IP3Rs
have lesser single-channel conductance than do RyRs [43,44].
The dimensions and tapering square profile of the channel region
of RyR (∼11.5 nm × 11.5 nm × 6 nm) [15] are similar to that of
recombinant IP3R1 (13.2 nm × 13.2 nm × 7.5 nm) (Figure 4B).
We note also that the large cytoplasmic region of RyR, like that of
recombinant IP3R1, has a large central cavity rather than a stigma
(Figure 4B).
In summary, we have provided the first three-dimensional
structure of a recombinant IP3R at a resolution of ∼40 Å. The
dimensions of our structure and its essential features are similar to
the shared structural features of IP3R purified from native sources
(Figure 4). This establishes the utility of recombinant IP3R and
EM and SPAs for further elaboration of the structural determinants
of IP3R behaviour.
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Figure S1 Estimated size of purified IP3R1 from gel filtration
Calibration of the Superose 6 10/300 GL column used for the final purification step allowed
the molecular mass of the purified IP3R1 to be estimated. The standards used were: ovalbumin,
43 kDa; conalbumin, 75 kDa; aldolase, 158 kDa; ferritin, 440 kDa; and thyroglobulin, 669 kDa
(gel filtration calibration kit HMW, GE Healthcare, ). The gel-phase distribution coefficient
(K av) was calculated from [1]: K av = (V e−V o)/(V c−V o) where V e is elution volume, V o is
void volume (determined using Blue Dextran), and V c is column volume. From the calibration
curve [K av against log molecular mass (MW), continuous line], K av for the purified IP3R1
suggests a molecular mass of 1.56 MDa (). Under the conditions used for IP3R1 purification
(0.02% DDM), the DDM micelle (aggregation number >140 for concentrations above the critical
micellar concentration) is likely to contribute a further molecular mass of at least 70 kDa. We
conclude that the observed mass (1.56 MDa) is consistent with the purified recombinant IP3R1
being a tetramer (4×339 kDa = 1.36 MDa) associated with DDM and perhaps also endogenous
lipids.
Figure S2 Euler angle distribution of final class averages
The Euler angle sphere shows the assigned Euler angles of the 22 class averages used to obtain
the final three-dimensional reconstruction. Each class average image is assigned three Euler
angles to describe the rotations that have to be performed to obtain the desired view of the
three-dimensional structure. The α angles are set to 0◦ and are not shown; the other two angles
define where the images are within the Euler sphere.
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Figure S3 Resolution of the final three-dimensional reconstruction
The Fourier shell correlation (FSC) coefficients were calculated for the two subsets of the final
class averages and plotted (black line) together with the half-bit curve (grey line). The resolution
of the final three-dimensional reconstruction, given by the crossing of the two curves, is
∼40 A˚.
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